These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7646451)

  • 1. 1 alpha,24(S)-dihydroxyvitamin D2: a biologically active product of 1 alpha-hydroxyvitamin D2 made in the human hepatoma, Hep3B.
    Strugnell S; Byford V; Makin HL; Moriarty RM; Gilardi R; LeVan LW; Knutson JC; Bishop CW; Jones G
    Biochem J; 1995 Aug; 310 ( Pt 1)(Pt 1):233-41. PubMed ID: 7646451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro metabolism of 19-nor-1alpha, 25-(OH)2D2 in cultured cell lines: inducible synthesis of lipid- and water-soluble metabolites.
    Shankar VN; Propp AE; Schroeder N; Surber BW; Makin HL; Jones G
    Arch Biochem Biophys; 2001 Mar; 387(2):297-306. PubMed ID: 11370854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-proliferative activity and target cell catabolism of the vitamin D analog 1 alpha,24(S)-(OH)2D2 in normal and immortalized human epidermal cells.
    Jones G; Byford V; Makin HL; Kremer R; Rice RH; deGraffenried LA; Knutson JC; Bishop CW
    Biochem Pharmacol; 1996 Jul; 52(1):133-40. PubMed ID: 8678897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unique 24-hydroxylated metabolites represent a significant pathway of metabolism of vitamin D2 in humans: 24-hydroxyvitamin D2 and 1,24-dihydroxyvitamin D2 detectable in human serum.
    Mawer EB; Jones G; Davies M; Still PE; Byford V; Schroeder NJ; Makin HL; Bishop CW; Knutson JC
    J Clin Endocrinol Metab; 1998 Jun; 83(6):2156-66. PubMed ID: 9626155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for the activation of 1alpha-hydroxyvitamin D2 by 25-hydroxyvitamin D-24-hydroxylase: delineation of pathways involving 1alpha,24-dihydroxyvitamin D2 and 1alpha,25-dihydroxyvitamin D2.
    Masuda S; Strugnell SA; Knutson JC; St-Arnaud R; Jones G
    Biochim Biophys Acta; 2006 Feb; 1761(2):221-34. PubMed ID: 16516540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of 1 alpha-hydroxyvitamin D2 to activated dihydroxyvitamin D 2 metabolites decreases endogenous 1 alpha, 25-dihydroxyvitamin D 3 in rats and monkeys.
    Knutson JC; Hollis BW; LeVan LW; Valliere C; Gould KG; Bishop CW
    Endocrinology; 1995 Nov; 136(11):4749-53. PubMed ID: 7588202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
    Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF
    Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and systemic effect on calcium homeostasis of 1 alpha,24-dihydroxyvitamin D2 in rats. Comparison with 1 alpha,25-dihydroxyvitamin D2, calcitriol, and calcipotriol.
    Knutson JC; LeVan LW; Valliere CR; Bishop CW
    Biochem Pharmacol; 1997 Mar; 53(6):829-37. PubMed ID: 9113104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioligand receptor assay for 25-hydroxyvitamin D2/D3 and 1 alpha, 25-dihydroxyvitamin D2/D3.
    Hughes MR; Baylink DJ; Jones PG; Haussler MR
    J Clin Invest; 1976 Jul; 58(1):61-70. PubMed ID: 1084355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological activity of 1,25-dihydroxyvitamin D2 and 24-epi-1,25-dihydroxyvitamin D2.
    DeLuca HF; Sicinski RR; Tanaka Y; Stern PH; Smith CM
    Am J Physiol; 1988 Apr; 254(4 Pt 1):E402-6. PubMed ID: 2833108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone-resorbing activities of 24-epi-1 alpha-hydroxyvitamin D2 and 24-epi-1 alpha,25-dihydroxyvitamin D2.
    Yokoyama K; Miyahara T; Matsumoto M; Hashimoto K; Komiyama H; Miyanishi A; Kotera N; Maruyama F; Kozuka H
    Calcif Tissue Int; 1995 Jan; 56(1):49-53. PubMed ID: 7796346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological activities of 24-fluoro-1 alpha,25-dihydroxyvitamin D-2 and its 24-epimer.
    Imae Y; Manaka A; Yoshida N; Ishimi Y; Shinki T; Abe E; Suda T; Konno K; Takayama H; Yamada S
    Biochim Biophys Acta; 1994 Aug; 1213(3):302-8. PubMed ID: 8049243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo metabolism of the vitamin D analog, dihydrotachysterol. Evidence for formation of 1 alpha,25- and 1 beta,25-dihydroxy-dihydrotachysterol metabolites and studies of their biological activity.
    Qaw F; Calverley MJ; Schroeder NJ; Trafford DJ; Makin HL; Jones G
    J Biol Chem; 1993 Jan; 268(1):282-92. PubMed ID: 8380156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The novel analog 1,24(S)-dihydroxyvitamin D2 is as equipotent as 1,25-dihydroxyvitamin D3 in growth regulation of cancer cell lines.
    Levy Y; Knutson JC; Bishop C; Shany S
    Anticancer Res; 1998; 18(3A):1769-75. PubMed ID: 9673403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of proliferation and induction of apoptosis by 25-hydroxyvitamin D3-3beta-(2)-Bromoacetate, a nontoxic and vitamin D receptor-alkylating analog of 25-hydroxyvitamin D3 in prostate cancer cells.
    Swamy N; Chen TC; Peleg S; Dhawan P; Christakos S; Stewart LV; Weigel NL; Mehta RG; Holick MF; Ray R
    Clin Cancer Res; 2004 Dec; 10(23):8018-27. PubMed ID: 15585637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and identification of 4,25-dihydroxyvitamin D2: a novel A-ring hydroxylated metabolite of vitamin D2.
    Rao DS; Dayal R; Siu-Caldera ML; Horst RL; Uskokovic MR; Tserng KY; Reddy GS
    J Steroid Biochem Mol Biol; 1999 Nov; 71(1-2):63-70. PubMed ID: 10619358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1,24(S)-dihydroxyvitamin D2, an endogenous vitamin D2 metabolite, inhibits growth of breast cancer cells and tumors.
    Zinser GM; Tribble E; Valrance M; Urben CM; Knutson JC; Mazess RB; Strugnell SA; Welsh J
    Anticancer Res; 2005; 25(1A):235-41. PubMed ID: 15816543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel analogs of 1,25-dihydroxyvitamin D
    Nachliely M; Sharony E; Kutner A; Danilenko M
    J Steroid Biochem Mol Biol; 2016 Nov; 164():59-65. PubMed ID: 26365556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Displacement potency of vitamin D2 analogs in competitive protein-binding assays for 25-hydroxyvitamin D3, 24,25-dihydroxyvitamin D3, and 1,25-dihydroxyvitamin D3.
    Jones G; Byrnes B; Palma F; Segev D; Mazur Y
    J Clin Endocrinol Metab; 1980 Apr; 50(4):773-5. PubMed ID: 6965943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 24,26-Dihydroxyvitamin D2: a unique physiological metabolite of vitamin D2.
    Koszewski NJ; Reinhardt TA; Napoli JL; Beitz DC; Horst RL
    Biochemistry; 1988 Jul; 27(15):5785-90. PubMed ID: 3263145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.